The intelligent asthma monitoring devices market has seen considerable growth due to a variety of factors.
• The intelligent asthma monitoring devices market has expanded rapidly in recent years. It is projected to grow from $1 billion in 2024 to $1.08 billion in 2025, at a CAGR of 8.5%.
Growth is driven by the development of new asthma diagnosis guidelines, favorable regulatory environments, increased approvals for asthma monitoring devices, a growing focus on preventive healthcare, and greater use of smart inhalers.
The intelligent asthma monitoring devices market is expected to maintain its strong growth trajectory in upcoming years.
• The intelligent asthma monitoring devices market is expected to grow to $1.48 billion by 2029 with a CAGR of 8.1%.
Growth is driven by the rising incidence of respiratory diseases, an aging population, urbanization, pollution, and an increase in asthma cases. Trends include collaborations between pharma companies and smart inhaler manufacturers, AI-driven asthma attack predictions, and integrating smart inhalers with digital health platforms.
The increasing prevalence of respiratory diseases is projected to drive the growth of the intelligent asthma monitoring device market. Respiratory diseases are rising due to factors such as air pollution, smoking, and an aging population. These devices provide real-time monitoring of lung function and environmental triggers, aiding early detection and personalized treatment. According to data from the American Lung Association, 5.09 million males in the U.S. were diagnosed with chronic obstructive pulmonary disease (COPD) in 2022, up from 4.82 million in 2021.
The intelligent asthma monitoring devices market covered in this report is segmented –
1) By Product: Wearable Asthma Monitoring Devices, Smart Inhalers, Inhalers, Dry Powdered Inhalers, Metered Dose Inhalers, Nebulizers
2) By Technology: Manually Operated Inhalers, Digitally Operated Inhalers, Other Technologies
3) By End User: Hospitals, Clinics, Retail Pharmacies, Online Pharmacies, Other End Users
Subsegments:
1) By Wearable Asthma Monitoring Devices: Smartwatches For Asthma Monitoring, Wearable Sensors And Patches
2) By Smart Inhalers: Bluetooth-Enabled Inhalers, Smart Inhalers With Medication Tracking
3) By Inhalers: Metered Dose Inhalers (MDI), Dry Powdered Inhalers (DPI)
4) By Dry Powdered Inhalers: Single-dose DPIs, Multi-Dose DPIs
5) By Metered Dose Inhalers: Conventional MDIs, MDIs With Dose Counters
6) By Nebulizers: Jet Nebulizers, Mesh Nebulizers, Ultrasonic Nebulizers
Leading firms in the intelligent asthma monitoring devices market are focusing on creating innovative solutions like app-based asthma management platform for a competitive advantage. This platform, accessible via a mobile app, enables users to log their asthma symptoms, get reminders for medication, and oversee peak flow. The platform also provides personalized advice for improved asthma control, with the goal of improving adherence to treatment strategies. For example, in May 2023, a medical equipment manufacturing company based in the US, CMI Health Inc., released AsthmaGo. AsthmaGo is an app-integrated platform for managing asthma that has been created to enable asthma patients to oversee and control their illness at home. This platform can connect with devices such as the SpiroLink spirometer and OxyKnight oximeter for immediate monitoring and data exchange with healthcare professionals.
Major companies operating in the intelligent asthma monitoring devices market are:
• AstraZeneca plc
• 3M Company
• Boehringer Ingelheim International GmbH
• Teva Pharmaceuticals Industries Ltd.
• ResMed Inc
• Aptar Pharma Inc
• OPKO Health Ltd
• Sensirion AG
• Vectura Group plc
• Circassia Pharmaceuticals
• Propeller Health
• Vitalograph Ltd
• Volansys Technologies Pvt Ltd
• Amiko Digital Health Inc
• Pneuma Respiratory Inc
• Quvium
• FindAir Sp. z o.
• Monitored Therapeutics Inc
• Respiri Ltd
• NuvoAir AB
• Health Care Originals Inc
• AEvice Health
North America was the largest region in the intelligent asthma monitoring devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the intelligent asthma monitoring devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.